Company intelligence / Profile preview

Vitrian

Bethesda, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Vitrian does not develop therapeutics directly, but accelerates advanced therapies to patients by building and financing cGMP manufacturing capacity and infrastructure for life sciences companies, targeting those progressing to late-stage clinical/approved products and CDMO partners. They report active projects supporting multi-modality drug manufacturing, including advanced biologics and cell therapies, with a broad national reach.[1][3][4][7]

Modalities: Small moleculeBiologicCell therapyRadiopharmaceuticalSynthetic biologyAseptic fill/finish
Industry: Contract Manufacturing Organization

Partnerships

cGMPnowAmplifyBioThe Howard Hughes CorporationKoelbel

Beyond the preview

Go deeper on Vitrian.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitrian.

Explore the full profile